Ambrx Biopharma Inc.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (A…
Biotechnology
US, La Jolla [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Ambrx Biopharma Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAmbrx Biopharma Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Ambrx Biopharma Inc..
If you want to see a demo, head over to the financial segments of AAPL